MARKET

PBE

PBE

Invesco Dynamic Biotech & Genome ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

58.98
-0.72
-1.21%
Closed 16:00 01/21 EST
OPEN
59.40
PREV CLOSE
59.70
HIGH
60.34
LOW
58.91
VOLUME
13.86K
TURNOVER
--
52 WEEK HIGH
84.86
52 WEEK LOW
58.91
TOTAL ASSET
277.04M
YTD YIELD
-2.33%
1D
5D
1M
3M
1Y
5Y
Quant ETFs With $564 Million Switch to Become Actively Managed
Bloomberg · 1d ago
Return Stacking to Solve the 60/40 Dilemma
Bloomberg · 1d ago
BlackRock Alumni Have a New Gameplan to Disrupt Junk-Debt ETFs
Bloomberg · 2d ago
Junk Debt Is Poised for Worst Month Since the Early Days of the Pandemic
Bloomberg · 2d ago
Wall Street Traders Place Fresh Bets on a Post-Covid World
Bloomberg · 2d ago
New Breakfast ETF Will Track Coffee, Orange Juice and Hogs
Bloomberg · 2d ago
State Street’s Fund Unit CEO Taraporevala to Retire in 2022
Bloomberg · 2d ago
Cathie Wood’s Ark Sees Near-Record Short Bets in Tech Wreck
Bloomberg · 01/10 18:28
More
No Data
Learn about the latest financial forecast of PBE. Analyze the recent business situations of Invesco Dynamic Biotech & Genome ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
08/31/2020
10 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-0.2580%
--
1-Week
-6.0909%
--
1-Month
-10.7878%
--
3-Month
-4.8963%
--
6-Month
7.1783%
--
YTD
-2.3282%
--
1-Year
11.1931%
--
3-Year
3.4889%
--
5-Year
0.9705%
--
10-Year
11.7333%
--
Since Inception
9.2415%
--
No Data
No Data
  • All
No Data
Profile
Fund Name
Invesco Dynamic Biotech & Genome ETF
Risk
Low risk
Inception Date
2005-06-23
Benchmark
Dow Jones US Healthcare TR
Advisor Company
Invesco
Custodian
The Bank of New York Mellon
Manager
Hubbard/Jeanette/Seisser